Lipid-lowering drug therapy | Antihypertensive drug therapy | |||
---|---|---|---|---|
Initiation | Intensification | Initiation | Intensification | |
OR*(95% CI) | OR(95% CI) | OR(95% CI) | OR(95% CI) | |
Age (per 10 years) | 0.7 (0.6–0.8) | - | 1.2 (1.1–1.3) | 1.1 (1.0–1.2) |
Gender | - | - | - | - |
HbA1c (%) | - | - | 0.9 (0.8–1.0) | - |
Systolic blood pressure (per 10 mmHg) | 1.1 (1.0–1.1) | - | 1.3 (1.2–1.4) | 1.1 (1.1–1.2) |
Diastolic blood pressure (per 10 mmHg) | - | - | 1.2 (1.0–1.4) | 1.1 (1.0–1.2) |
TC/HDL ratio | 1.8 (1.6–1.9) | 1.3 (1.1–1.5) | 1.2 (1.1–1.3) | - |
History of MI/AP | 1.9 (1.4–2.5) | - | 2.3 (1.6–3.3) | - |
Year of screening | 1.3 (1.2–1.4) | 0.9 (0.8–1.0) | 1.1 (1.1–1.2) | 1.1(1.1–1.1) |